Guardion Health Sciences, Inc. (GHSI): Price and Financial Metrics
GET POWR RATINGS... FREE!
GHSI POWR Grades
- Sentiment is the dimension where GHSI ranks best; there it ranks ahead of 61.62% of US stocks.
- GHSI's strongest trending metric is Sentiment; it's been moving up over the last 59 days.
- GHSI ranks lowest in Stability; there it ranks in the 0th percentile.
GHSI Stock Summary
- GHSI has a higher market value than only 0.38% of US stocks; more precisely, its current market capitalization is $6,375,445.
- The volatility of Guardion Health Sciences Inc's share price is greater than that of 95.7% US stocks with at least 200 days of trading history.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for GHSI comes in at -598.04% -- higher than that of only 0.54% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Guardion Health Sciences Inc are MNSB, SUNW, ESQ, ASPU, and OGI.
- Visit GHSI's SEC page to see the company's official filings. To visit the company's web site, go to www.guardionhealth.com.
GHSI Valuation Summary
- GHSI's price/sales ratio is 17.2; this is 51.54% higher than that of the median Healthcare stock.
- GHSI's price/earnings ratio has moved up 7.1 over the prior 29 months.
- GHSI's price/sales ratio has moved down 63.2 over the prior 29 months.
Below are key valuation metrics over time for GHSI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| GHSI | 2021-08-31 | 17.2 | 0.8 | -2.6 | -2.2 |
| GHSI | 2021-08-30 | 16.9 | 0.8 | -2.5 | -2.1 |
| GHSI | 2021-08-27 | 17.4 | 0.8 | -2.6 | -2.2 |
| GHSI | 2021-08-26 | 17.7 | 0.9 | -2.7 | -2.2 |
| GHSI | 2021-08-25 | 17.3 | 0.8 | -2.6 | -2.2 |
| GHSI | 2021-08-24 | 18.3 | 0.9 | -2.7 | -2.3 |
GHSI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- GHSI has a Quality Grade of D, ranking ahead of 6.18% of graded US stocks.
- GHSI's asset turnover comes in at 0.071 -- ranking 291st of 677 Pharmaceutical Products stocks.
- PBH, TXMD, and NVS are the stocks whose asset turnover ratios are most correlated with GHSI.
The table below shows GHSI's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.071 | -0.042 | -3.780 |
| 2021-03-31 | 0.093 | -0.050 | -7.284 |
| 2020-12-31 | 0.147 | -0.030 | -5.816 |
| 2020-09-30 | 0.142 | 0.509 | -5.190 |
| 2020-06-30 | 0.144 | 0.507 | -5.304 |
| 2020-03-31 | 0.085 | 0.606 | -6.883 |
GHSI Stock Price Chart Interactive Chart >
GHSI Price/Volume Stats
| Current price | $0.16 | 52-week high | $1.98 |
| Prev. close | $0.17 | 52-week low | $0.14 |
| Day low | $0.16 | Volume | 849,300 |
| Day high | $0.17 | Avg. volume | 5,580,380 |
| 50-day MA | $0.21 | Dividend yield | N/A |
| 200-day MA | $0.76 | Market Cap | 9.77M |
Guardion Health Sciences, Inc. (GHSI) Company Bio
Guardion Health Sciences, Inc. provides health care services. It offers, Lumega-Z a medical food formulated to replenish and restore the macular protective pigment. The firm also develops medical devices that measures macular pigment density. The company was founded by Michael Favish in 2009 and is headquartered in San Diego, CA.
Latest GHSI News From Around the Web
Below are the latest news stories about Guardion Health Sciences Inc that investors may wish to consider to help them evaluate GHSI as an investment opportunity.
Guardion Health Sciences, Inc. Announces Closing of $11 Million Public OfferingHOUSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced the closing of a previously announced public offering of 37,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Class A warrants to purchase up to 37,000,000 shares of its common stock and Class B warrants to purchase up to 37,0 |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGood morning! |
Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public OfferingHOUSTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced the pricing of a previously announced public offering of 37,000,000 shares of its common stock (or common stock equivalents in lieu thereof), Class A warrants to purchase up to 37,000,000 shares of its common stock and Class B warrants to purchase up to 37,0 |
Guardion Health Sciences, Inc. Announces Proposed Public OfferingHOUSTON, TEXAS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, today announced that it intends to offer and sell, shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase shares of common stock in a public offering. All of the securities to be sold in the offering are to be offered by Gua |
Guardion Health Sciences Launches New Viactiv® Omega BOOST™ Passion Fruit Flavored Gel BitesNew Omega BOOST™ Gel Bites Provide 10x More Omega-3 Than Leading Gummies Individually Packaged in Blisterpacks to Ensure Freshness and Portability Omega BOOST™ is the First New Viactiv® Product Launch Since Guardion Acquired the Brand in June 2021 HOUSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announced the launch of V |
GHSI Price Returns
| 1-mo | -22.74% |
| 3-mo | -20.32% |
| 6-mo | -85.32% |
| 1-year | -89.87% |
| 3-year | -98.20% |
| 5-year | N/A |
| YTD | -75.27% |
| 2021 | -74.01% |
| 2020 | 88.38% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...